Image

A Registry Study of Biomarkers in Progression of Acute Heart Failure(BIOMS-POAHF)

A Registry Study of Biomarkers in Progression of Acute Heart Failure(BIOMS-POAHF)

Recruiting
18-80 years
All
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

The registry study aims to discover the prognostic value of bio-markers in acute heart failure

Eligibility

Inclusion Criteria:

  • 1. Patients aged greater than or equal to 18 years with acute exacerbation of chronic heart failure or new heart failure
  • 2. With typical symptoms of acute heart failure as follows: Dyspnea, ankle swelling and fatigue (Limited activity endurance), increased jugular pressure, rales and peripheral edema ;
  • 3. Plasma concentrations of BNP: BNP>100pg/ML
  • 4. Echocardiography: Related structural heart disease (left ventricular hypertrophy and/or left atrial enlargement) and/or diastolic dysfunction

Exclusion Criteria:

  • 1. Previous history of cancer or renal replacement therapy
  • 2.Surgery was performed within a month
  • 3.Accompanied by cardiogenic shock, sepsis, pneumonia
  • 4.Eligible patients without informed consent form

Study details
    Cardiovascular Diseases

NCT04108182

Beijing Institute of Heart, Lung and Blood Vessel Diseases

27 January 2024

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.